1. 18F-FDG PET/CT and sentinel lymph node biopsy in the staging of patients with cervical and endometrial cancer. Role of dual-time-point imaging
- Author
-
Aureli Torné, Pilar Paredes, Jaume Ordi, Francisco Lomeña, Andrés Tapias, B. Doménech, Maria Mayoral, F. Pons, Pere Fusté, Sergi Vidal-Sicart, and Jaume Pahisa
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Sentinel lymph node ,030218 nuclear medicine & medical imaging ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,Biopsy ,medicine ,Radiology, Nuclear Medicine and imaging ,Prospective cohort study ,Cervix ,General Environmental Science ,Cervical cancer ,PET-CT ,medicine.diagnostic_test ,business.industry ,Endometrial cancer ,Micrometastasis ,General Engineering ,Cancer ,medicine.disease ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,General Earth and Planetary Sciences ,Lymphadenectomy ,Radiology ,Lymph ,Nuclear medicine ,business - Abstract
Objective Definitive staging for cervical (CC) and endometrial cancer (EC) takes place once surgery is performed. The aim of this study was to evaluate the role of PET/CT in detecting lymphatic metastasis in patients with CC and EC using dual-time-point imaging (DPI), taking the histopathological results of sentinel lymph node (SLN) and lymphadenectomy as the reference. Material and methods A prospective study was conducted on 17 patients with early CC, and 13 patients with high-risk EC. The patients had a pre-operative PET/CT, MRI, SLN detection, and lymphadenectomy, when indicated. PET/CT findings were compared with histopathological results. Results In the pathology study, 4 patients with CC and 4 patients with EC had lymphatic metastasis. PET/CT showed hypermetabolic nodes in 1 patient with CC, and 5 with EC. Four of these had metastasis, one detected in the SLN biopsy. Four patients who had negative PET/CT had micrometastasis in the SLN biopsy, 1 patient with additional lymph nodes involvement. The overall patient-based sensitivity, specificity, positive and negative predictive values, and accuracy of PET/CT to detect lymphatic metastasis was 20.0%, 100.0%, 100.0%, 87.9%, and 88.2%, respectively, in CC, and 57.1%, 88.9%, 66.7%, 84.2% and 80.0%, respectively, in EC. DPI showed higher retention index in malignant than in inflammatory nodes, although no statistically significant differences were found. Conclusions PET/CT has low sensitivity in lymph node staging of CC and EC, owing to the lack of detection of micrometastasis. Thus, PET/CT cannot replace SLN biopsy. Although no statistically significant differences were found, DPI may help to differentiate between inflammatory and malignant nodes.
- Published
- 2017
- Full Text
- View/download PDF